PIROXICAM

Piroxicam Adverse Events Reported to the FDA Over Time

How are Piroxicam adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Piroxicam, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Piroxicam is flagged as the suspect drug causing the adverse event.

Most Common Piroxicam Adverse Events Reported to the FDA

What are the most common Piroxicam adverse events reported to the FDA?

Drug Interaction	36 (1.92%)
Pyrexia	31 (1.66%)
Pain	22 (1.18%)
Gastrointestinal Haemorrhage	21 (1.12%)
Pancytopenia	21 (1.12%)
Vitreous Haemorrhage	21 (1.12%)
Cardiac Arrest	20 (1.07%)
Gastric Ulcer	18 (.96%)
Haemoglobin Decreased	18 (.96%)
Abdominal Pain	17 (.91%)
Dyspnoea	17 (.91%)
	Show More
Dizziness	16 (.85%)
Drug Ineffective	16 (.85%)
Rash	16 (.85%)
Urticaria	16 (.85%)
Bone Marrow Failure	15 (.8%)
Completed Suicide	15 (.8%)
Duodenal Ulcer	15 (.8%)
Headache	15 (.8%)
Diarrhoea	14 (.75%)
Drug Hypersensitivity	14 (.75%)
Alanine Aminotransferase Increased	13 (.69%)
Anaemia	13 (.69%)
Death	13 (.69%)
Eye Pain	13 (.69%)
Melaena	13 (.69%)
Vomiting	13 (.69%)
Asthenia	12 (.64%)
Intestinal Diaphragm Disease	12 (.64%)
Renal Failure Acute	12 (.64%)
Respiratory Arrest	12 (.64%)
Fatigue	11 (.59%)
Haemorrhage	11 (.59%)
Hypersensitivity	11 (.59%)
Vision Blurred	11 (.59%)
Arthralgia	10 (.53%)
Drug Toxicity	10 (.53%)
General Physical Health Deteriorati...	10 (.53%)
Haematochezia	10 (.53%)
Inflammation	10 (.53%)
Musculoskeletal Stiffness	10 (.53%)
Nausea	10 (.53%)
Oedema	10 (.53%)
Syncope	10 (.53%)
Weight Decreased	10 (.53%)
Rash Maculo-papular	9 (.48%)
Spondylitis	9 (.48%)
Blood Pressure Increased	8 (.43%)
Cough	8 (.43%)
Gastritis	8 (.43%)
Hyperhidrosis	8 (.43%)
Hypotension	8 (.43%)
Myocardial Infarction	8 (.43%)
Renal Failure	8 (.43%)
Weight Increased	8 (.43%)
Blood Creatinine Increased	7 (.37%)
Cardio-respiratory Arrest	7 (.37%)
Constipation	7 (.37%)
Eosinophilia	7 (.37%)
Eye Haemorrhage	7 (.37%)
Lymphadenopathy	7 (.37%)
Oedema Peripheral	7 (.37%)
Pruritus	7 (.37%)
Tachycardia	7 (.37%)
Abdominal Pain Upper	6 (.32%)
Back Pain	6 (.32%)
Blister	6 (.32%)
Contusion	6 (.32%)
Cytolytic Hepatitis	6 (.32%)
Diverticulitis	6 (.32%)
Drug Rash With Eosinophilia And Sys...	6 (.32%)
Dyspepsia	6 (.32%)
Haematemesis	6 (.32%)
Myocardial Ischaemia	6 (.32%)
Pallor	6 (.32%)
Swelling Face	6 (.32%)
Toxic Epidermal Necrolysis	6 (.32%)
Anaphylactic Shock	5 (.27%)
Angioedema	5 (.27%)
Apparent Death	5 (.27%)
Bacteraemia	5 (.27%)
Bone Pain	5 (.27%)
Chest Pain	5 (.27%)
Colitis Ulcerative	5 (.27%)
Condition Aggravated	5 (.27%)
Diffuse Large B-cell Lymphoma	5 (.27%)
Drug Level Increased	5 (.27%)
Duodenal Ulcer Haemorrhage	5 (.27%)
Duodenal Ulcer Perforation	5 (.27%)
Gastrointestinal Ulcer	5 (.27%)
Gastrooesophageal Reflux Disease	5 (.27%)
Helicobacter Infection	5 (.27%)
Hepatic Failure	5 (.27%)
Hyperkalaemia	5 (.27%)
Intestinal Perforation	5 (.27%)
Knee Arthroplasty	5 (.27%)
Malaise	5 (.27%)
Oliguria	5 (.27%)
Operative Haemorrhage	5 (.27%)
Peritonitis	5 (.27%)
Pulmonary Embolism	5 (.27%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Piroxicam, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Piroxicam is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Piroxicam

What are the most common Piroxicam adverse events reported to the FDA?

Epidermal And Dermal Conditions	113 (6.04%)
Gastrointestinal Ulceration And Per...	84 (4.49%)
Gastrointestinal Hemorrhages	72 (3.85%)
Gastrointestinal Signs	68 (3.63%)
Neurological	66 (3.53%)
Respiratory	62 (3.31%)
Therapeutic And Nontherapeutic Effe...	57 (3.04%)
Anemias Nonhemolytic And Marrow Dep...	56 (2.99%)
Cardiac Arrhythmias	46 (2.46%)
Hepatic And Hepatobiliary	40 (2.14%)
Hematology Investigations	37 (1.98%)
	Show More
Gastrointestinal Inflammatory Condi...	35 (1.87%)
Allergic Conditions	33 (1.76%)
Renal Disorders	33 (1.76%)
Body Temperature Conditions	31 (1.66%)
Infections - Pathogen Unspecified	31 (1.66%)
Gastrointestinal Motility And Defec...	29 (1.55%)
Joint	28 (1.5%)
Hepatobiliary	26 (1.39%)
Gastrointestinal Stenosis And Obstr...	25 (1.34%)
Physical Examination Topics	23 (1.23%)
Angiedema And Urticaria	22 (1.18%)
Retina, Choroid And Vitreous Hemorr...	22 (1.18%)
Cardiac And Vascular Investigations	19 (1.01%)
Coronary Artery	19 (1.01%)
Musculoskeletal And Connective Tiss...	19 (1.01%)
Suicidal And Self-injurious Behavio...	19 (1.01%)
Chemical Injury And Poisoning	18 (.96%)
Bacterial Infectious	17 (.91%)
Eye	16 (.85%)
Headaches	16 (.85%)
Injuries	16 (.85%)
Medication Errors	16 (.85%)
White Blood Cell	15 (.8%)
Fatal Outcomes	14 (.75%)
Vision	14 (.75%)
Electrolyte And Fluid Balance Condi...	13 (.69%)
Muscle	13 (.69%)
Water, Electrolyte And Mineral	13 (.69%)
Administration Site Reactions	12 (.64%)
Decreased And Nonspecific Blood Pre...	12 (.64%)
Vascular Hemorrhagic	12 (.64%)
Oral Soft Tissue Conditions	11 (.59%)
Procedural And Device Related Injur...	11 (.59%)
Skin Appendage Conditions	11 (.59%)
Anxiety Disorders	10 (.53%)
Renal And Urinary Tract Investigati...	10 (.53%)
Metabolic, Nutritional And Blood Ga...	9 (.48%)
Peritoneal And Retroperitoneal Cond...	9 (.48%)
Vascular	9 (.48%)
Appetite And General Nutritional	8 (.43%)
Bone And Joint Therapeutic Procedur...	8 (.43%)
Lower Respiratory Tract Disorders	8 (.43%)
Lifestyle Issues	7 (.37%)
Myocardial	7 (.37%)
Ocular Hemorrhages And Vascular	7 (.37%)
Platelet	7 (.37%)
Sleep Disorders	7 (.37%)
Spleen, Lymphatic And Reticulendoth...	7 (.37%)
Tissue	7 (.37%)
Toxicology And Therapeutic Drug Mon...	7 (.37%)
Viral Infectious	7 (.37%)
Bone Disorders	6 (.32%)
Bronchial Disorders	6 (.32%)
Acid-base	5 (.27%)
Bone And Joint Injuries	5 (.27%)
Cardiac And Vascular Disorders Cong...	5 (.27%)
Cardiac Valve	5 (.27%)
Central Nervous System Vascular	5 (.27%)
Depressed Mood Disorders	5 (.27%)
Gastrointestinal Conditions	5 (.27%)
Heart Failures	5 (.27%)
Lymphomas Non-hodgkins B-cell	5 (.27%)
Movement Disorders	5 (.27%)
Pleural	5 (.27%)
Psychiatric	5 (.27%)
Pulmonary Vascular	5 (.27%)
Anal And Rectal Conditions	4 (.21%)
Dental And Gingival Conditions	4 (.21%)
Encephalopathies	4 (.21%)
Hearing	4 (.21%)
Immunology And Allergy	4 (.21%)
Lipid Analyses	4 (.21%)
Mental Impairment	4 (.21%)
Musculoskeletal And Connective Tiss...	4 (.21%)
Thoracic Disorders	4 (.21%)
Upper Respiratory Tract Disorders	4 (.21%)
Enzyme	3 (.16%)
Exocrine Pancreas Conditions	3 (.16%)
Gastrointestinal	3 (.16%)
Gastrointestinal Vascular Condition...	3 (.16%)
Hematological And Lymphoid Tissue T...	3 (.16%)
Lymphomas	3 (.16%)
Musculoskeletal And Connective Tiss...	3 (.16%)
Nephropathies	3 (.16%)
Ocular Infections, Irritations And ...	3 (.16%)
Pericardial	3 (.16%)
Skin Vascular Abnormalities	3 (.16%)
Therapeutic Procedures And Supporti...	3 (.16%)
Tongue Conditions	3 (.16%)
Urinary Tract Signs	3 (.16%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Piroxicam, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Piroxicam is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.